DESIPRAMINE for Mantle cell lymphoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 9 adverse event reports in the FDA FAERS database where DESIPRAMINE was used for Mantle cell lymphoma.
Most Reported Side Effects for DESIPRAMINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Completed suicide | 85 | 20.0% | 85 | 20 |
| Toxicity to various agents | 55 | 12.9% | 53 | 9 |
| Weight increased | 48 | 11.3% | 0 | 1 |
| Drug hypersensitivity | 43 | 10.1% | 0 | 1 |
| Drug ineffective | 43 | 10.1% | 0 | 11 |
| Therapy non-responder | 41 | 9.6% | 0 | 0 |
| Immune thrombocytopenia | 37 | 8.7% | 0 | 0 |
| Acute kidney injury | 26 | 6.1% | 0 | 21 |
| Loss of consciousness | 24 | 5.6% | 15 | 3 |
| Off label use | 22 | 5.2% | 7 | 7 |
| Overdose | 21 | 4.9% | 15 | 6 |
| Urinary retention | 21 | 4.9% | 0 | 18 |
| Intestinal obstruction | 19 | 4.5% | 0 | 17 |
| Drug interaction | 18 | 4.2% | 13 | 1 |
| Cardio-respiratory arrest | 17 | 4.0% | 17 | 7 |
Other Indications for DESIPRAMINE
Product used for unknown indication (173)
Complex regional pain syndrome (41)
Depression (25)
Schizoaffective disorder (13)
Antidepressant therapy (5)
Bipolar disorder (5)
Irritable bowel syndrome (5)
Neuralgia (5)
Other Drugs Used for Mantle cell lymphoma
IBRUTINIB (6,306)
RITUXIMAB (3,940)
LENALIDOMIDE (2,989)
CYCLOPHOSPHAMIDE (1,815)
DOXORUBICIN (1,396)
VENETOCLAX (1,367)
VINCRISTINE (1,361)
BENDAMUSTINE (1,227)
CYTARABINE (1,174)
DEXAMETHASONE (949)